Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FY8MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,762
Award facts
- Contract value 100% obligated
- $30,762.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,762.29 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. The contract, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award. Repatha is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular disease, and this delivery order supports federal medical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates significant capability in pharmaceutical distribution, with delivery orders consistently awarded through competitive procedures and involving firm fixed pricing across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FY8MA?
SPE2DR26FY8MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FY8MA worth?
The government has obligated $30,762 on SPE2DR26FY8MA.
Is contract SPE2DR26FY8MA an order under another contract?
Yes. SPE2DR26FY8MA is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8MA competed?
The extent of competition for SPE2DR26FY8MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award